Junjian Li
State Key Laboratory Of Systems Medicine For Cancer, Shanghai 20080
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A small-molecule compound cocktail for tumor reprogramming therapy for breast cancer.
Journal: International immunopharmacology
Published: April 17, 2025
TFDP1 drives triple-negative breast Cancer development through senescence suppression and serves as a therapeutic target for topotecan.
Journal: International journal of biological macromolecules
Published: January 27, 2025
Targeting SNRPE to Induce Pyroptosis Enhances Antitumor Immunity in Breast Cancer.
Journal: International journal of medical sciences
Published: December 21, 2024
A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles.
Journal: Theranostics
Published: September 15, 2024
TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer.
Journal: Science translational medicine
Published: April 03, 2024
Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer.
Journal: Cancer research
Published: December 16, 2023
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription.
Journal: Cell research
Published: August 11, 2021
Nuclear translocation of the 4-pass transmembrane protein Tspan8.
Journal: Cell research
Published: January 26, 2021
SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer.
Journal: Oncogene
Published: November 04, 2020
Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
Journal: Journal of hematology & oncology
Published: October 20, 2020
Last Updated: 09/26/2026